Abraxane pancreatic cancer early phase I/II trial results
Standard warning about cross-trial comparison, but there's one head-to-head trial of a regimen (FOLFIRINOX) vs. Gemzar that showed efficacy results in the same ballpark. Safety/tolerability is one problem with this regimen.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.